drugset / Trial / NCT00078637
Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a first-in-man, open-label, non-randomized, multiple dose, multiple cycle, dose escalation study to determine the MTD, safety, PK, and pharmacodynamics of E7820 in patients with a malignant solid tumor or lymphoma.
Timeline
- Start
- 2004-01
- Primary completion
- 2006-08
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E7820 | Small molecule | — | Oral |